MedTrace Logo

Mail-in HPV Screening Program in NJ

NCT07575217 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-05-08

No results posted yet for this study

Summary

The purpose of this study is to help people who have missed their regular cervical cancer screening. The investigators are evaluating whether mailing an HPV self-sampling kit to participant home makes it easier and more convenient for people to get screened for cervical cancer. This study will also help to understand if people find this process acceptable and whether it is an effective way to improve screening rates.

Conditions

  • Cervical Cancer Screening

Interventions

DIAGNOSTIC_TEST

BD Onclarity HPV test

Self-collected cervicovaginal sample

DIAGNOSTIC_TEST

Standard Pap Smear

Healthcare provider collected (in a hospital or clinical setting) cervicovaginal sample

Sponsors & Collaborators

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Ana Tergas, MD, MPH · Rutgers, The State University of New Jersey

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2027-02-28
Completion
2027-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07575217 on ClinicalTrials.gov